Strategic Initiative

Slingshot members are tracking this corporate initiative:

Novogen (NVGN) Licenses GDC-0084 for Gioblastoma from Genentech (RHBBY)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RHHBY

100%
NVGN

100%
Genentech

100%
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Oct 31, 2016
Projected Implementation:
Q4, 2016
Relevance Tracked Until:
Q4, 2018
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Gdc-0084, Gioblastoma, Licensing Agreement